Familial Nasopharyngeal Carcinoma 6

Prognostic Factors in Nasopharyngeal Cancer 129Ang KK, Peters LJ, Weber RS, Maor MH, Morrison WH, WendtCD, Brown BW (1990) Concomitant boost radiotherapyschedules in the treatment of carcinoma of the oropharynxand nasopharynx. Int J Radiat Oncol Biol Phys 19:1339–1345Au JS, Law CK, Foo W, Lau WH (2003) In-depth evaluation ofthe AJCC/UICC 1997 staging system of nasopharyngealcarcinoma: prognostic homogeneity and proposed refinements.Int J Radiat Oncol Biol Phys 56:413–426August M, Dodson TB, Nastri A, Chuang SK (2001)Nasopharyngeal carcinoma: clinical assessment and reviewof 176 cases. Oral Surg Oral Med Oral Pathol Oral RadiolEndod 91:205–214Bailet JW, Mark RJ, Abemayor E, Lee SP, Tran LM, Juillard G,Ward PH (1992) Nasopharyngeal carcinoma: treatmentresults with primary radiation therapy. Laryngoscope102:965–972Barnes L, Eveson JW, Reichart P, Sidransky D (2005) Worldhealth organization classification of tumors: pathologyand genetics of head and neck tumors. IARC Press, Lyon,FranceBar-Sela G, Ben Arush MW, Sabo E, Kuten A, Minkov I, Ben-Izhak O (2005) Pediatric nasopharyngeal carcinoma: betterprognosis and increased c-Kit expression as comparedto adults. Pediatr Blood Cancer 45:291–297Bar-Sela G, Kaplan-Cohen V, Ilan N, Vlodavsky I, Ben-Izhak O (2006)Heparanase expression in nasopharyngeal carcinoma inverselycorrelates with patient survival. Histopathology 49:188–193Baujat B, Audry H, Bourhis J, Chan AT, Onat H, Chua DT, KwongDL, Al-Sarraf M, Chi KH, Hareyama M, Leung SF,Thephamongkhol K, Pignon JP; MAC-NPC CollaborativeGroup (2006) Chemotherapy in locally advanced nasopharyngealcarcinoma: an individual patient data meta-analysisof eight randomized trials and 1753 patients. Int J RadiatOncol Biol Phys 64:47–56Bhattacharyya N (2004) The impact of race on survival innasopharyngeal carcinoma: a matched analysis. Am JOtolaryngol 25:94–97Bourhis J, Overgarrd J, Audry H, Ang KK, Saunders M, BernierJ, Horiot JC, Le Maître A, Pajak TF, Poulsen MG, O’SullivanB, Dobrowsky W, Hliniak A, Skladowski K, Hay JH, PintoLH, Fallai C, Fu KK, Sylvester R, Pignon JP; Meta-Analysisof Radiotherapy in Carcinomas of Head and neck (MARCH)Collaborative Group (2006) Hyperfractionated or acceleratedradiotherapy in head and neck cancer: a meta-analysis.Lancet 68:843–854Burt RD, Vaughan TL, McKnight B (1992) Descriptive epidemiologyand survival analysis of nasopharyngeal carcinomain the United States. Int J Cancer 52:549–556Casselman JW (1994) The value of MRI in the diagnosis andstaging of nasopharynx tumors. J Belge Radiol 77:67–71Chan AT, Teo PM, Leung TW, Leung SF, Lee WY, Yeo W, ChoiPH, Johnson PJ (1995) A prospective randomized study ofchemotherapy adjunctive to definitive radiotherapy inadvanced nasopharyngeal carcinoma. Int J Radiat OncolBiol Phys 33:569–577Chan AT, Teo ML, Lee WY, Kwan WH, Choi PH, Johnson PJ(1998) The significance of keratinizing squamous cell histologyin Chinese patients with nasopharyngeal carcinoma.Clin Oncol (R Coll Radiol) 10:161–164Chan AT, Lo YM, Zee B, Chan LY, Ma BB, Leung SF, Mo F, Lai M,Ho S, Huang DP, Johnson PJ (2002a) Plasma Epstein–Barrvirus DNA and residual disease after radiotherapy forundifferentiated nasopharyngeal carcinoma. J Natl CancerInst 94:1614–1619Chan AT, Teo PM, Ngan RK, et al (2002b) Concurrent chemotherapy–radiotherapycompared with radiotherapy alonein locoregionally advanced nasopharyngeal carcinoma:progression-free survival analysis of a phase III randomizedtrial. J Clin Oncol 20:2038–2044Chan AT, Leung SF, Ngan RK, Teo PM, Lau WH, Kwan WH, HuiEP, Yiu HY, Yeo W, Cheung FY, Yu KH, Chiu KW, Chan DT,Mok TS, Yau S, Yuen KT, Mo FK, Lai MM, Ma BB, Kam MK,Leung TW, Johnson PJ, Choi PH, Zee BC (2005) Overall survivalafter concurrent cisplatin-radiotherapy compared withradiotherapy alone in locoregionally advanced nasopharyngealcarcinoma. J Natl Cancer Inst 97:536–539Chan CM, Ma BB, Hui EP, Wong SC, Mo FK, Leung SF, Kam MK,Chan AT (2007) Cyclooxygenase-2 expression in advancednasopharyngeal carcinoma–a prognostic evaluation andcorrelation with hypoxia inducible factor 1a and vascularendothelial growth factor. Oral Oncol 43:373–378Chan KC, Zhang J, Chan AT, Lei KI, Leung SF, Chan LY, ChowKC, Lo YM (2003) Molecular characterization of circulatingEBV DNA in the plasma of nasopharyngeal carcinoma andlymphoma patients. Cancer Res 63:2028–2032Chan SC, Chang JT, Wang HM, Lin CY, Ng SH, Fan KH, Chin SC,Liao CT, Yen TC (2009) Prediction for distant failure inpatients with stage M0 nasopharyngeal carcinoma: the roleof standardized uptake value. Oral Oncol 45:52–58Chang CC, Chen MK, Liu MT, Wu HK (2002) The effect of primarytumor volumes in advanced T-staged nasopharyngealtumors. Head Neck 24:940–946Chang JT, See LC, Tang SG, Lee SP, Wang CC, Hong JH (1996)The role of brachytherapy in early-stage nasopharyngealcarcinoma. Int J Radiat Oncol Biol Phys 36:1019–1024Chang JT, Lin CY, Chen TM, Kang CJ, Ng SH, Chen IH, WangHM, Cheng AJ, Liao CT (2005) Nasopharyngeal carcinomawith cranial nerve palsy: the importance of MRI for radiotherapy.Int J Radiat Oncol Biol Phys 63:1354–1360Chang KP, Hao SP, Chang JH, Wu CC, Tsang NM, Lee YS, HsuCL, Ueng SH, Liu SC, Liu YL, Wei PC, Liang Y, Chang YS, YuJS (2008) Macrophage inflammatory protein-3a is a novelserum marker for nasopharyngeal carcinoma detectionand prediction of treatment outcomes. Clin Cancer Res14:6979–6987Chang YS, Tyan YS, Liu ST, Tsai MS, Pao CC (1990) Detection ofEpstein–Barr virus DNA sequences in nasopharyngeal carcinomacells by enzymatic DNA amplification. J ClinMicrobiol 28:2398–2402Chen CL, Wen WN, Chen JY, Hsu MM, Hsu HC (1993) Detectionof Epstein–Barr virus genome in nasopharyngeal carcinomaby in situ DNA hybridization. Intervirology 36:91–98Chen HH, Tsai ST, Wang MS, Wu YH, Hsueh WT, Yang MW, YehIC, Lin JC (2006) Experience in fractionated stereotactic bodyradiation therapy boost for newly diagnosed nasopharyngealcarcinoma. Int J Radiat Oncol Biol Phys 66:1408–1414Chen KW, Lin JF, Jan JS, Chao JY, Lin JC (2009) The effect ofprimary tumor volume measured by MR imaging onT-stage, local control, and survival in patients withadvanced nasopharyngeal carcinoma. Therapeut RadiolOncol 16:1–13Chen MK, Chen TH, Liu JP, Chang CC, Chie WC (2004) Betterprediction of prognosis for patients with nasopharyngeal carcinomausing primary tumor volume. Cancer 100:2160–2166